Analysts forecast Abbott Laboratories to post 1.6% earnings growth and 6%-8% revenue rise backed by recent acquisitions. Abbott Laboratories (ABT) is set to release second-quarter results on July 15, with analysts projecting $1.28 earnings per share, a 1.6% increase from t
America made 1,200 new millionaires every day last year — the 4 disciplined habits legendary investors say actually work Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below. According to a new UBS Global Wealth Report (1), the
Verastem Inc. (NASDAQ:VSTM) is one of the 10 best stocks under $10 that could triple. On July 7, RBC Capital maintained its Outperform rating on Verastem Inc. (NASDAQ:VSTM) The firm reduced the target price from $15 to $14, which still offers a revised upside potent
Sable Offshore retains over 180% upside despite Jefferies slashing its price target by more than half to $11. Jefferies analyst Lloyd Byrne lowered Sable Offshore Corp. (NYSE:SOC) price target from $24 to $11 on July 6, citing recent challenges including equity dilution fr
LRMR submits initial Biologics License Application for rare disease therapy, targeting accelerated approval based on surrogate endpoint data. Larimar Therapeutics submitted the first module of its Biologics License Application to the FDA for Nomlabofusp, seeking accelerate
AtaiBeckley joins Russell 2000 and 3000 indices AtaiBeckley N.V. will be included in the Russell indices, with over $12 trillion in assets benchmarked to these indexes. The company will join the small-cap focused Russell 2000 Index and the broader Russell 3000 Inde
Sharplink Inc. (NASDAQ:SBET) is one of the 10 best stocks under $10 that could triple. On June 30, Sharplink Inc. (NASDAQ:SBET) disclosed that it had purchased 10,000 Ether at an average price of $1,611 per ETH This lifts its cumulative holdings to 886,725 tokens. T
Omeros Corp. (NASDAQ:OMER) is one of the 10 best stocks under $10 that could triple. On June 26, Omeros Corp. (NASDAQ:OMER) released an update regarding the Committee for Medicinal Products for Human Use's (CHMP) review of a marketing authorization application for the comp
ARS Pharmaceuticals Inc. (NASDAQ:SPRY) is one of the 10 best stocks under $10 that could triple. On July 8, ARS Pharmaceuticals Inc. (NASDAQ:SPRY) disclosed a CEO transition, and effective July 6, the company's Co-founder and Chief Executive Officer, Richard Lowenthal, wil
Sagimet Biosciences Inc. (NASDAQ:SGMT) is one of the 10 best stocks under $10 that could triple. On June 29, Sagimet Biosciences Inc. (NASDAQ:SGMT) announced that it had been included in the broader Russell 3000 Index and the small-cap focused Russell 2000 Index, as part o
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.